ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2
Lung Cancer
◽
10.1016/j.lungcan.2006.01.001
◽
2006
◽
Vol 52
(3)
◽
pp. 313-317
◽
Cited By ~ 1
Author(s):
Charles H. Weissman
◽
John Sandbach
◽
Reginald Brooker
◽
Mark Vellek
◽
Deborah Lindquist
◽
...
Keyword(s):
Lung Cancer
◽
Cancer Patients
◽
Phase Ii Study
◽
Performance Status
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Weekly Docetaxel
◽
And Performance
Download Full-text
Related Documents
Cited By
References
A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age < 65 and performance status 2
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7122
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7122-7122
◽
Cited By ~ 1
Author(s):
J. F. Sandbach
◽
C. Weissman
◽
R. Brooker
◽
D. Ilegbodu
◽
L. Asmar
Keyword(s):
Lung Cancer
◽
Cancer Patients
◽
Phase Ii Study
◽
Performance Status
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Weekly Docetaxel
◽
And Performance
Download Full-text
A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7276
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7276-7276
Author(s):
C. H. Weissman
◽
J. F. Sandbach
◽
R. J. Brooker
◽
D. Ilegbodu
◽
L. Asmar
Keyword(s):
Lung Cancer
◽
Cancer Patients
◽
Phase Ii Study
◽
Performance Status
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Weekly Docetaxel
◽
And Performance
Download Full-text
A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age < 65 and performance status 2
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7122
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7122-7122
Author(s):
J. F. Sandbach
◽
C. Weissman
◽
R. Brooker
◽
D. Ilegbodu
◽
L. Asmar
Keyword(s):
Lung Cancer
◽
Cancer Patients
◽
Phase Ii Study
◽
Performance Status
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Weekly Docetaxel
◽
And Performance
Download Full-text
A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7276
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7276-7276
Author(s):
C. H. Weissman
◽
J. F. Sandbach
◽
R. J. Brooker
◽
D. Ilegbodu
◽
L. Asmar
Keyword(s):
Lung Cancer
◽
Cancer Patients
◽
Phase Ii Study
◽
Performance Status
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Weekly Docetaxel
◽
And Performance
Download Full-text
CarVin versus CarEto - A randomised phase II study of carboplatin and vinorelbine versus carboplatin and etoposide in good performance status small cell lung cancer patients presenting with adverse prognostic factors
http://isrctn.org/>
◽
10.1186/isrctn44486227
◽
2012
◽
Author(s):
Ernie Marshall
Keyword(s):
Lung Cancer
◽
Prognostic Factors
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Performance Status
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
Download Full-text
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
Case Medical Research
◽
10.31525/ct1-nct04253964
◽
2020
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Pilot Study
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Cell Lung Cancer
◽
Performance Status
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
Download Full-text
Clinical Benefit of Chemotherapy for Small-Cell Lung Cancer Patients with Extremely Poor Performance Status (PS)
Annals of Cancer Research and Therapy
◽
10.4993/acrt.26.1
◽
2018
◽
Vol 26
(1)
◽
pp. 1-6
Author(s):
Ou Yamaguchi
◽
Hiroshi Kagamu
◽
Atsuto Mouri
◽
Ayako Shiono
◽
Harue Utsugi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Clinical Benefit
◽
Performance Status
◽
Poor Performance
◽
Small Cell
◽
Poor Performance Status
◽
Small Cell Lung
◽
Lung Cancer Patients
Download Full-text
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
Annals of Oncology
◽
10.1093/annonc/mdm061
◽
2007
◽
Vol 18
(5)
◽
pp. 903-908
◽
Cited By ~ 14
Author(s):
S. Novello
◽
P. Bruzzi
◽
C. Barone
◽
R. Buosi
◽
A. Masotti
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Cell Lung Cancer
◽
Stage Iv
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Phase Iii Study
Download Full-text
MA15.07 Survival Benefit From Immunocheckpoint Inhibitors in Stage IV Non-small Cell Lung Cancer Patients ≥75 Years Old of Age
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.08.193
◽
2021
◽
Vol 16
(10)
◽
pp. S936
Author(s):
S. Takamori
◽
T. Komiya
◽
E. Powell
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Cell Lung Cancer
◽
Survival Benefit
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
◽
Lung Cancer Patients
Download Full-text
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
Annals of Oncology
◽
10.1093/annonc/mdh087
◽
2004
◽
Vol 15
(3)
◽
pp. 419-426
◽
Cited By ~ 116
Author(s):
C. Gridelli
◽
A. Ardizzoni
◽
T. Le Chevalier
◽
C. Manegold
◽
F. Perrone
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Cell Lung Cancer
◽
Performance Status
◽
Small Cell
◽
Small Cell Lung
◽
Ecog Performance Status
◽
Lung Cancer Patients
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close